A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology. Continuous glucose monitors, ...

The FDA is warning health providers and patients to avoid use of smart devices like watches and rings that purport to measure glucose levels without piercing the skin, the agency announced Feb. 21.

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." For people with prediabetes, type 1 diabetes or type 2 diabetes, monitoring blood glucose levels is a ...

Global healthcare company, Abbott, announced that its continuous glucose monitoring system Lingo can now be purchased in the U.S. without a prescription. Lingo contains a biosensor and mobile app that ...

The U.S. Food and Drug Administration has cleared the first over-the-counter monitor that continuously checks glucose levels. The Stelo Glucose Biosensor System, a wearable sensor that pairs with a ...

Diabetes prevalence continues to rise worldwide, creating sustained demand for monitoring solutions. Obesity, sedentary behavior, and unhealthy diets contribute to higher diagnosis rates. Many ...

The recent US Food and Drug Administration (FDA) clearance of two over-the-counter (OTC) continuous glucose monitors (CGMs) — Dexcom’s Stelo and Abbott’s Lingo — has sparked interest in potentially ...

It's a small device, but the hype around it is huge. The technology is called constant glucose monitoring, and companies that make it say it will transform the way you feel. But what do scientific ...

In recent years, smartwatches and smart rings have grown increasingly popular, adorning the wrists and fingers of consumers who use them to monitor their exercise, sleep and heart activity. Now, ...

SUNDAY EVEN MORE ENJOYABLE. PEOPLE WITH DIABETES OFTEN HAVE TO MEASURE THEIR BLOOD SUGAR. SEVERAL TIMES A DAY. THAT INVOLVES THE FINGER STICK. NOW, THE FDA HAS RELEASED AN OVER THE COUNTER CONTINUOUS ...

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is ...